Posted in | News | Mining Business

U.S. Rare Earths Receives Approval for Drill Permit on Sheep Creek Property

U.S. Rare Earths, Inc., a rare earths exploration company with mining claims in Idaho, Montana, and Colorado, is pleased to announce it has received approval for its drill permit on its Sheep Creek property in Montana.

"Sheep Creek gives us five permits across three states," said Kevin Cassidy , CEO and Director of U.S. Rare Earths. "We now have the opportunity to take a district approach on our Idaho and Montana properties." The Company's permit for its Lemhi Pass, Idaho property is pending. The Company's drill program, which began in 2011 in Colorado and moved to Idaho in 2012, will focus on Idaho and Montana for the 2013 season.

Receipt of the Sheep Creek drill permit follows the results from U.S. Rare Earths' 2012 drill program at its Diamond Creek, Idaho property. Drill core assay results show total Rare Earth Elements mineralization > 0.5% at Drill Hole No.1 and a second intersection of REE mineralization in Drill Hole No. 2 at a depth of 12 meters with assays returning approximately 0.2% total Rare Earth Elements content. Analysis on the core samples was provided by Activation Laboratories of Ontario, Canada. Surface channel samples from Diamond Creek support the drilling results and -- when combined with surface spectrometer readings -- indicate that the mineralized trend is a minimum of 40 meters long and estimated to be about 1 meter in true thickness.

U.S. Rare Earths' properties in Idaho and Montana, including Lemhi Pass, have been recognized in the U.S. Department of Energy's Critical Materials Strategy publications to have significant showings of Heavy Rare Earth Elements, in particular for the five Rare Earths identified by DOE as being at "Critical Risk": Dysprosium, Europium, Neodymium, Terbium and Yttrium.

Source: http://www.usrareearths.com/eco/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.